autoimmune disease and semaglutide Disease: Safety and Clinical Guidelines Semaglutide and Autoimmune Diseases (Ozempic

Mechanism of Action GLP-1R agonism enhances glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying, and reduces appetite GIPR agonism amplifies insulin secretion additively

This is why providers often encourage patience when starting treatment

GLP-1 drugs linked to lower rates of some cancers July 16, 2024 Source: Wang, et al, JAMA Network Open, July 5, 2024 LINK Obesity is associated with increased risk of multiple cancers, including breast cancer, colorectal cancer, and endometrial cancer

In reality, follow-up after stopping medication is equally important

Progress photos taken under consistent lighting conditions help visualize changes

You can also see if your local pharmacy or healthcare centre accepts used Ozempic pens